Any documents listed and made available below does not constitute an invitation, offer or advice to any person to market, sell, offer or buy the bonds. Be informed that the bonds are only suitable for qualified investors and selling restrictions ad tax implications may apply in certain jurisdictions.
Our Term Sheet sets forth the basic legal and financial terms and conditions that apply to the bond. Investors should only rely on the specific terms and conditions outlined in the Offering Memorandum. The Term Sheet is a non-binding document. Only a signed (Pre)subscription Agreement will bind the parties.
The Offering Memorandum is a legal binding document that states the exact terms and conditions of the investment amongst other critical information to be considered by prospective investors like the risks, the responsibilities and all applicable (references to) regulatory, governance, compliance, fiscal and accounting rules.
After the (Pre)Subscription Agreement has been signed by the parties It serves at the single point of legal reference and cannot be amended without the explicit consent of the parties.
The Fact Book provides the investor with significant background information on the performance of the underlying portfolio and individual assets including all key financial ratios, correlated market risks and the underlying business key drivers of revenue, cost and value. The first Fact Book will be published at the 2nd anniversary of the bond and availability of fully audit statements.
The credit rating report provides an independent evaluation of the applicable credit risk, predicting our ability to pay back the debt, and implicit forecast of the likelihood of default. The first credit-rating report of the designated rating agency will be published in the 3rd anniversary of the bond
The Pre-Subscription Form is a non-binding letter of intent expressing the prospective investor's interest to purchase the bonds. The Issuer utilizes this form to make inventory of the interest and determine the actual issue size prior to commencing the final offering period.
The Subscription Agreement is legally committing the investor to invest in the bonds and committing the Issuer to certain obligations and warranties. In some jurisdictions bespoke contract drafting by a qualified specialist may be required.
Lux Life Sciences is a true financial innovator. Beyond our capital-protected social impact bonds, we offer a unique blend of fixed-income stability and strategic risk management anchored in high-impact healthcare assets.
